Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Paragon 28 Inc (FNA)

Paragon 28 Inc (FNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Insider Sale: 10% owner at $FNA (FNA) Sells 25,485 Shares

Partners, LLC MVM, a 10% owner of $FNA ($FNA), sold 25,485 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2% of their shares....

FNA : 10.03 (+2.35%)
Is TMDX Stock a Buy, Sell or Hold at a P/S Multiple of 5.02X?

TransMedics Group TMDX is a key player in transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The company offers Organ Care System, an integrated, compact,...

TCMD : 17.00 (+0.29%)
FNA : 10.03 (+2.35%)
TMDX : 61.70 (+1.93%)
Insider Sale: 10% owner at $FNA (FNA) Sells 72,133 Shares

Partners, LLC MVM, a 10% owner of $FNA ($FNA), sold 72,133 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.7% of their shares....

FNA : 10.03 (+2.35%)
Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance

Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or "Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter...

FNA : 10.03 (+2.35%)
Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO,...

FNA : 10.03 (+2.35%)
Paragon 28 Launches Phantom® Metatarsal Shortening System

Paragon 28, Inc. (NYSE: FNA), is pleased to announce the launch of its Phantom® Metatarsal Shortening System which features a first in-kind intramedullary device for fixation of in-line shortening osteotomies...

FNA : 10.03 (+2.35%)
Paragon 28 To Report First Quarter Financial Results on May 4, 2023

Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the first quarter...

FNA : 10.03 (+2.35%)
Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance

Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter and year ended...

FNA : 10.03 (+2.35%)
Paragon 28 to Present at Upcoming Investor Conferences

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO,...

FNA : 10.03 (+2.35%)
Paragon 28, Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock

Paragon 28, Inc. (NYSE: FNA) (“Paragon”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today completion of the sale of an additional 975,000...

FNA : 10.03 (+2.35%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar